Wetenschappelijk

Wetenschap en onderzoek naar naaldangst en prikweerstand

Wetenschap en praktijk

Afgelopen decennia zijn er uiteenlopende onderzoeken geweest naar problemen rondom het prikken met de naald. In Engeland zijn daaruit voortkomend wetenschappelijke richtlijnen ontwikkeld hoe naaldangst bij kinderen te benaderen [10, 11]. Het implementeren van deze richtlijnen gaat erg traag [61]. Ook in Nederland is er helaas weinig wetenschappelijke inbedding in de praktijk bekend. Hier is dus nog veel ruimte en noodzaak voor verbetering.

Wetenschappelijke artikelen

Hieronder vindt u een aanzienlijke lijst met wetenschappelijke literatuur zo die deels gebruikt is voor het handboek Naaldangst en Prikweerstanden (in press).

[1] P. Szmuk, E. Szmuk, and T. Ezri, “Use of needle-free injection systems to alleviate

needle phobia and pain at injection,” Expert Review of Pharmacoeconomics &

Outcomes Research, vol. 5, no. 4, pp. 467–477, Aug. 2005.

[2] J. Hamilton, “Needle phobia neglected diagnosis.” 1995.

[3] G. J. Andrews and D. Shaw, “‘So we started talking about a beach in Barbados’:

Visualization practices and needle phobia,” Social Science & Medicine, vol. 71,

no. 10, pp. 1804–1810, Nov. 2010.

[4] A. P. Asociation, DSM IV, Diagnostic and Statistical Manual. 1994.

[5] B. P. N. Wickramasuriya, A. Casey, S. Akhtar, R. Zia, S. Ehtisham, T. G. Barrett, N.

J. Shaw, and J. M. W. Kirk, “Factors determining patient choice of device for GH

therapy,” Hormone research, vol. 65, no. 1, pp. 18–22, Jan. 2006.

[6] P. P. Network, Y. People, and B. P. Society, “Evidence-based Guidelines for the

Management of Invasive and / or Distressing Procedures with Children,” no.

October, 2009.

[7] R. R. Kapoor, S. a Burke, S. E. Sparrow, I. a Hughes, D. B. Dunger, K. K. Ong, and C.

L. Acerini, “Monitoring of concordance in growth hormone therapy,” Archives of

disease in childhood, vol. 93, no. 2, pp. 147–8, Feb. 2008.

[8] “Guidance on the Use of Human Growth Hormone (Somatropin) in Children

with Growth Failure,” Technology Appraisal Guidance, 2002

[9] WHO, “Injection safety,” Report by the secretariat. Health Organization Executive

Board, vol. 107th Sess, 2000.

[10] Network, Paediatric Psychology People, Young Society, British Psychological,

“Evidence-based Guidelines for the Management of Invasive and / or

Distressing Procedures with Children,” October, 2009.

[11] a. J. a. Duff, S. L. Gaskell, K. Jacobs, and J. M. Houghton, “Management of

distressing procedures in children and young people: time to adhere to the

guidelines,” Archives of Disease in Childhood, vol. 97, no. 1, pp. 1–4, Nov. 2011.

[12] C. et. al. Bennett, “The Occurrence and of High Adolescents Levels of Acute

Behavioral Distress Undergoing Routine Venipunctures in Children,” vol. 90, no.

1, pp. 87–91, 1992.

[13] A. Hermann, A. Schäfer, B. Walter, R. Stark, D. Vaitl, and A. Schienle, “Diminished

medial prefrontal cortex activity in blood-injection-injury phobia.,” Biological

psychology, vol. 75, no. 2, pp. 124–30, May 2007.

130

[14] E. S. Ayala, A. E. Meuret, and T. Ritz, “Treatments for blood-injury-injection

phobia: a critical review of current evidence.,” Journal of psychiatric research,

vol. 43, no. 15, pp. 1235–42, Oct. 2009.

[15] Wieling, Ganzeboom & Saul Reflex syncope in children and adolescents (2004)

Heart. 2004 September; 90(9): 1094–1100

[16] Bracha, H. (2006). “Human brain evolution and the “Neuroevolutionary Timedepth

Principle:” Implications for the Reclassification of fear-circuitry-related

traits in DSM-V and for studying resilience to warzone-related posttraumatic

stress disorder”. Progress in Neuro-Psychopharmacology and Biological

Psychiatry 30 (5): 827–853

[17] M. van Overveld, P. J. de Jong, and M. L. Peters, “The Multi-Dimensional Blood/

Injury Phobia Inventory: its psychometric properties and relationship with

disgust propensity and disgust sensitivity,” Journal of anxiety disorders, vol. 25,

no. 3, pp. 319–25, Apr. 2011.

[18] Woody & Teachman, “Intersection of disgust and fear: normative and

pathological views,” Clinical Psychology, Science and Practice, vol. 7, pp.

291–311, 2000.

[19] T. C. Tolin, D.F., Lohr, J.M., Sawchuk, C.N., Lee, “Disgust and disgust sensitivity in

blood-injection-injury and spider phobia,” Behaviour Research and Therapy,

vol. 35, pp. 949–953, 1997.

[20] E. L. Grunau, V.E., Whitfield, M.F., Petrie, J.H., Fryer, “Early pain experience, child

and family factors, as precursors of somatization: a prospective study of

extremely premature and fullterm children,” Pain, vol. 56, no. 3, pp. 353–359,

1994.

[21] Schouw R.H.J.A., Vroege pijn, kijk uit voor de hersenen! Lange-termijn effecten

van neontale pijn ervaringen. Proefschrift, Erasmus Universiteit Rotterdam.

[22] A. Buskila, D., Neuman, L., Zmora E., Feldman, M., Bolotin, “Pain sensitivity in

premature born Adolecents,” Arch Pediatric Adolsc Md, vol. 157, pp. 1079–1089,

2003.

[23] H. Hermann, C., Hofmeister, J., Demrakca, S., Zohsel K., Flor, “Long-term

alteration of pain sensitivity in school-aged children with early pain

experiences,” Pain, vol. 125, no. 3, pp. 278–285, 2006.

[24] J. Hands, C., Round, J., Thomas, “When someone stabs you: children’s

perspectives of venepuncture,” Arch Dis Child, vol. 94, p. 499, 2009.

[25] R. Hanas and J. Ludvigsson, “Experience of pain from insulin injections and

needle-phobia in young patients with IDDM,” Practical Diabetes International,

vol. 14, no. 4, pp. 95–99, 1997.

[26] D. Cox and J. Stone, “Managing Self-Injection Diffculties in Patients with

Relapsing-Remitting Multiple Sclerosis,” Journal of Neuroscience Nursing, vol.

38, no. 3, pp. 167–171, Jun. 2006.

[27] S. A. Counseling, D. C. Mohr, D. Ph, D. Cox, D. Psy, and A. Boudewyn, “SELF-

INJECTION ANXIETY COUNSELING ( SIAC ) MANUAL FOR COUNSELORS For

Use with the Patient Workbook,” pp. 1–36, 2003.

[28] Cloughertry, “For parents Overcoming a fear of needles.” 2003.

[29] D. C. Mohr, D. Ph, D. Cox, and D. Psy, “LEARNING TO SELF-INJECT : APPROACH

TO OVERCOMING INJECTION ANXIETY University of California San Francisco,”

2003.

[30] D. C. Mohr, a C. Boudewyn, W. Likosky, E. Levine, and D. E. Goodkin, “Injectable

medication for the treatment of multiple sclerosis: the influence of self-effcacy

expectations and injection anxiety on adherence and ability to self-inject,”

Annals of behavioral medicine : a publication of the Society of Behavioral

Medicine, vol. 23, no. 2, pp. 125–32, Jan. 2001.

[31] C. N. E. Tompkins, S. Ghoneim, N. M. J. Wright, L. Sheard, and L. Jones, “Needle

fear among women injecting drug users: a qualitative study,” Journal of

Substance Use, vol. 12, no. 4, pp. 281–291, Jan. 2007.

[32] J. Van den Berg, Bloednerveus en Prikkelende Oplossingen: gratis

informatieboek voor mensen met een angst en afkeer van bloed, verwondingen

en naalden. Angstbehandelcentrum IPZO, 2012.

[33] Website Rijksoverheid, http://www.rijksoverheid.nl/onderwerpen/mexicaansegriep/

vaccinatie-mexicaanse-griep

[34] WHO, “Injection safety,” vol. Fact sheet, 2006.

[35] Y. Nir, A. Paz, E. Sabo, and I. Potasman, “FEAR OF INJECTIONS IN YOUNG

ADULTS : PREVALENCE AND ASSOCIATIONS,” vol. 68, no. 3, pp. 341–344, 2003.

[36] C. CG., “Fears and phobias in women: a community study,” J. Abnorm. Psychol.

91, pp. 280–286, 1982.

[37] W.O. Arvidsson SB, Ekroth RH, Hansby AM, Lindholm AH, “Painless

venipuncture. A clinical trial of iontophoresis of lidocaine for venipuncture in

blood donors,” Acta Anaesthesiol. Scand, vol. 28, pp. 209–10, 1984.

[38] G. J. Oswalt R, “Blood donor motivation: a survey of minority college students,”

Psychol. Rep., vol. 72, pp. 785–786, 1993.

[39] E. W. Bienvenu OJ, “The epidemiology of blood- injection-injury phobia.,”

Psychol Med, vol. 28, pp. 1129–1136, 1998.

[40] D. H. Antony, M. M., Brown, T. A., & Barlow, “Heterogeneity among specific

phobia types in DSM-IV,” Behaviour Research and Therapy, vol. 35 (12), pp.

1089–1100, 1997.

[41] O. D. Agras S, Sylvester D, “The epidemiology of common fears and phobia,”

Comprehensive chiat, vol. 10, pp. 151–56, 1969.

[42] M. Vika, M. Raadal, E. Skaret, and G. Kvale, “Dental and medical injections:

prevalence of self-reported problems among 18-yr-old subjects in Norway,”

European Journal of Oral Sciences, vol. 114, no. 2, pp. 122–127, Apr. 2006.

[43] S. Finger, Origins of Neuroscience: A History of Explorations Into Brain Function.

Oxford University Press, 1994.

[44] J. Fenster, Ether Day: The Strange Tale of America’s Greatest Medical Discovery

and the Haunted Men Who Made It. York, HarperCollins, 2001.

[45] N. J. Cuper, R. M. Verdaasdonk, R. de Roode, and E. Septer, “Development

and clinical trial of a practical vessel imaging system for vessel punctures in

children,” Proceedings of SPIE, vol. 6848, pp. 684806–684806–10, 2008.

[46] K. J. Zengerink I, Brink PR, Laupland KB, Raber EL, Zygun D, “Needle

thoracostomy in the treatment of a tension pneumothorax in trauma patients:

what size needle?,” J Trauma, vol. 64 (1), pp. 111–4, 20087.

[47] G. H. Verrips, R. a Hirasing, M. Fekkes, T. Vogels, S. P. Verloove-Vanhorick, and H.

a Delemarre-Van de Waal, “Psychological responses to the needle-free Medi-

Jector or the multidose Disetronic injection pen in human growth hormone

therapy,” Acta paediatrica (Oslo, Norway : 1992), vol. 87, no. 2, pp. 154–8, Feb.

1998.

[48] C. M. G. J. Houtzagers, Insuline delivery Systems. Calff & Meischke, 1989, p. 120.

[49] M. K. (eds) Newman S, Steed L, Chronic physical ilness: Self-management and

behavioural interventions. Open University Press, 2009.

[50] R. A. Kleinknecht, “Dimensions of blood/injury and medically related fears:

development of the Medical Fears Survey,” Paper presented to the 25th Annual

Meeting of the Association for Advancement of Behavior Therapy, New York,

1991.

[51] K. Page, A. C., Bennett, K. S., Carter, O., Smith, J., & Woodmore, “The blood-

injection symptom scale (BISS): assessing a structure of phobic symptoms

elicited by blood and injections,” Behaviour Research and Therapy, vol. 35, pp.

457–464, 1997.

[52] A. Öst, L.-G., Hellström, K., & Käver, “One versus five sessions of exposure in the

treatment of injection phobia,” Behavior Therapy, vol. 23, pp. 263–282, 1992.

[53] H. de Jong, P., & Merckelbach, “Blood-injection-injury phobia and fear of spi-

ders: domain specific individual differences in disgust sensitivity,” Personality

and Individual Differences, vol. 24, pp. 153–158, 1998.

[54] L. Yim, “Belonephobia,” vol. 35, no. 8, pp. 623–624, 2006.

[55] RIVM, “Vacinatie Programma Rijksoverheid.” [Online]. Available: http://www.

rivm.nl/Onderwerpen/Onderwerpen/R/Rijksvaccinatieprogramma/De_

inenting/Vaccinatieschema?gclid=CIjF5JaU3bICFUPHtAodwx8ArQ.

[56] S. Aspects, “Adolescents ’ Compliance with Therapeutic Regimens,” pp. 52–67,

1987.

[57] T. E. D. & P. C. Wolfram R.W., “Effects of parental presence during young children’s

venepuncture,” Pediatric Emergency Care, vol. 13, pp. 325–358, 1997.

[58] R. L. Blount, B. Landolf-Fritsche, S. W. Powers, and J. W. Sturges, “Differences

Between High and Low Coping Children and Between Parent and Staff

Behaviors During Painful Medical Procedures,” Journal of Pediatric Psychology,

vol. 16, no. 6, pp. 795–809, 1991.

[59] G. E. Gunter, R. W., & Bodner, “How eye movements affect unpleasant

memories: Support for a working memory account.,” Behaviour Research and

Therapy, vol. 46, pp. 913–931, 2008.

[60] T. I. Usichenko, D. Pavlovic, S. Foellner, and M. Wendt, “Reducing Venipuncture

Pain by a Cough Trick: A Randomized Crossover Volunteer Study,” Anesthesia &

Analgesia, pp. 343–345, Feb. 2004.

[61] A. J. A. Duff, S. L. Gaskell, K. Jacobs, and J. M. Houghton, “Management of

distressing procedures in children and young people : time to adhere to the

guidelines PAEDIATRIC PSYCHOLOGY NETWORK,” 2011.

[62] S. L. Eds. . Bergin, A. E., & Garfield, Handbook of psychotherapy and behavior

change, 5th ed. New York: John Wiley & Sons, 1994.

[63] B. P. Klok T, Sulkers EJ, Kaptein AA, Duiverman EJ, “Therapietrouw bij chronisch

zieken. Patiëntgerichte benadering is noodzakelijk,” Ned. Tijdschrift Geneeskd,

p. 153:A420, 2009.

[64] S. C. Kettwich, W. L. Sibbitt, J. R. Brandt, C. R. Johnson, C. S. Wong, and a. D.

Bankhurst, “Needle Phobia and Stress-Reducing Medical Devices in Pediatric

and Adult Chemotherapy Patients,” Journal of Pediatric Oncology Nursing, vol.

24, no. 1, pp. 20–28, Jan. 2007.

[65] B. P. N. Wickramasuriya, a Casey, S. Akhtar, R. Zia, S. Ehtisham, T. G. Barrett, N. J.

Shaw, and J. M. W. Kirk, “Factors determining patient choice of device for GH

therapy,” Hormone research, vol. 65, no. 1, pp. 18–22, Jan. 2006.

[66] R. R. Kapoor, S. a Burke, S. E. Sparrow, I. a Hughes, D. B. Dunger, K. K. Ong, and C.

L. Acerini, “Monitoring of concordance in growth hormone therapy,” Archives of

disease in childhood, vol. 93, no. 2, pp. 147–8, Feb. 2008.

[67] “Guidance on the Use of Human Growth Hormone (Somatropin) in Children

with Growth Failure,” Technology Appraisal Guidance, 2002.

[68] S. Masud, R. D. Wasnich, J. L. Ruckle, W. T. Garland, S. W. Halpern, D. Mee-

Lee, M. a Ashburn, and J. C. Campbell, “Contribution of a heating element

to topical anesthesia patch effcacy prior to vascular access: results from

two randomized, double-blind studies.,” Journal of pain and symptom

management, vol. 40, no. 4, pp. 510–9, Oct. 2010.

[69] P. Thom, A., Sartory, G. & Johren, “Comparison between one-session

psychological treatment and benzodiazepine in dental phobia,” Journal of

Consulting and Clinical Psychology, vol. 68, pp. 378–387, 2000.

[70] & W. M. . Antony M.M., Ovecoming medical phobias. New Harbinger

Publications, Inc, 2006.

[71] Kaptein A, “De patient de baas, in Therapietrouw is teamwork”

[72] D. Orlemans, J.W.G., Eelen, P., Hermans, Inleiding tot de gedragstherapie. Bohn

Stafleu Van Loghum, 1997.

[73] I. M. Marks, Living with fear: Understanding and coping with anxiety. McGraw-

Hill, 1978.

[74] J. P. R. W. Trijsburg, M. Jelicic, W. W. van den Broek, J. E. M. Plekker, R. Verheij,

“Gedragstherapeutische behandeling van naaldfobie,” Tijdschrift voor Psychotherapie, vol. 18, no. 6, pp. 215–222, 1992.

[75] de L. Horne DJ, McCormack H. Behavioural psychotherapy for a blood and needle phobic mastectomy patient receiving adjuvant chemotherapy. Behavioral Psychotherapy

Terug naar boven